The current VRML market cap is 497.78M. The company's latest EPS is USD -0.2183 and P/E is -18.32.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.07M | 2.15M | 2.32M | 2.49M | 2.22M |
Operating Income | -9.7M | -5.6M | -5.77M | -4.32M | -4.63M |
Net Income | -4.56M | -5.1M | -6.07M | -2.32M | -5.22M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.05M | 4.54M | 4.65M | 6.81M | 8.18M |
Operating Income | -11.33M | -15.28M | -17.98M | -32.6M | -32.77M |
Net Income | -11.37M | -15.24M | -17.91M | -31.66M | -27.17M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 23.94M | 17.37M | 11.5M | 7.72M | 8.66M |
Total Liabilities | 12.76M | 10.64M | 10.67M | 8.25M | 9.32M |
Total Equity | 11.18M | 6.73M | 827k | -528k | -659k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.41M | 13.83M | 19.61M | 41.08M | 17.37M |
Total Liabilities | 4.26M | 5.09M | 9.89M | 10.91M | 10.64M |
Total Equity | 7.15M | 8.74M | 9.72M | 30.17M | 6.73M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -25.11M | -32.19M | -5.71M | -9.12M | -12.44M |
Investing | -158k | -232k | -8k | -12k | -12k |
Financing | 8.64M | 8.54M | -55k | 79k | 4.26M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.37M | -12.97M | -14.73M | -27.4M | -32.19M |
Investing | -113k | -132k | -490k | -184k | -232k |
Financing | 13.3M | 15.44M | 20.15M | 48.38M | 8.54M |
Market Cap | 497.78M |
Price to Earnings Ratio | -18.32 |
Price to Sales Ratio | 60.79 |
Price to Cash Ratio | 37.42 |
Price to Book Ratio | 73.95 |
Dividend Yield | - |
Shares Outstanding | 124.45M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.25 (6.17%) |
Company Name | Vermillion Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://aspirawh.com |
Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.